Proteomics-Based Characterization of miR-574-5p Decoy to CUGBP1 Suggests Specificity for mPGES-1 Regulation in Human Lung Cancer Cells

Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2020.00196
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Frontiers Media SA

Related search

MiR-129-5p Sensitization of Lung Cancer Cells to Etoposide-Induced Apoptosis by Reducing YWHAB

Journal of Cancer
Oncology
2020English

miR-654-5p Targets HAX-1 to Regulate the Malignancy Behaviors of Colorectal Cancer Cells

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2020English

Overexpression of miR‑361‑5p Plays an Oncogenic Role in Human Lung Adenocarcinoma Through the Regulation of SMAD2

International Journal of Oncology
Cancer ResearchOncology
2018English

miR-339-5p Downregulation Contributes to Taxol Resistance in Small-Cell Lung Cancer by Targeting Α1,2-Fucosyltransferase 1

IUBMB Life
BiochemistryGeneticsClinical BiochemistryCell BiologyMolecular Biology
2017English

Tubeimoside‑1 Inhibits the Proliferation and Metastasis by Promoting miR‑126‑5p Expression in Non‑small Cell Lung Cancer Cells

Oncology Letters
Cancer ResearchOncology
2018English

Human Papillomavirus 16 Oncoproteins Downregulate the Expression of miR-148a-3p, miR-190a-5p, and miR-199b-5p in Cervical Cancer

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2018English

Coordinated Regulation of ATF2 by miR-26b in Γ-Irradiated Lung Cancer Cells

PLoS ONE
Multidisciplinary
2011English

The Clinical Significance of Downregulation of Mir-124-3p, Mir-146a-5p, Mir-155-5p and Mir-335-5p in Gastric Cancer Tumorigenesis

International Journal of Oncology
Cancer ResearchOncology
2014English

Inhibition of mPGES-1 or COX-2 Results in Different Proteomic and Lipidomic Profiles in A549 Lung Cancer Cells

Frontiers in Pharmacology
Pharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy